Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 14 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 1 |
GO:0005759 | mitochondrial matrix | 5 | 1 |
GO:0020023 | kinetoplast | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0035770 | ribonucleoprotein granule | 3 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0099080 | supramolecular complex | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3S7XBP0
Term | Name | Level | Count |
---|---|---|---|
GO:0000959 | mitochondrial RNA metabolic process | 6 | 1 |
GO:0000963 | mitochondrial RNA processing | 6 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0009894 | regulation of catabolic process | 4 | 1 |
GO:0009895 | negative regulation of catabolic process | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010467 | gene expression | 4 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0010628 | positive regulation of gene expression | 6 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016553 | base conversion or substitution editing | 6 | 1 |
GO:0016554 | cytidine to uridine editing | 7 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 1 |
GO:0031329 | regulation of cellular catabolic process | 5 | 1 |
GO:0031330 | negative regulation of cellular catabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043487 | regulation of RNA stability | 3 | 1 |
GO:0043488 | regulation of mRNA stability | 4 | 1 |
GO:0043489 | RNA stabilization | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044528 | regulation of mitochondrial mRNA stability | 5 | 1 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 6 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0048255 | mRNA stabilization | 5 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048523 | negative regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0051253 | negative regulation of RNA metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0061013 | regulation of mRNA catabolic process | 6 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:0140053 | mitochondrial gene expression | 5 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1902369 | negative regulation of RNA catabolic process | 7 | 1 |
GO:1902373 | negative regulation of mRNA catabolic process | 7 | 1 |
GO:1903311 | regulation of mRNA metabolic process | 6 | 1 |
GO:1903312 | negative regulation of mRNA metabolic process | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 266 | 270 | PF00656 | 0.395 |
CLV_NRD_NRD_1 | 100 | 102 | PF00675 | 0.557 |
CLV_NRD_NRD_1 | 140 | 142 | PF00675 | 0.529 |
CLV_NRD_NRD_1 | 218 | 220 | PF00675 | 0.475 |
CLV_PCSK_KEX2_1 | 100 | 102 | PF00082 | 0.592 |
CLV_PCSK_KEX2_1 | 185 | 187 | PF00082 | 0.395 |
CLV_PCSK_KEX2_1 | 218 | 220 | PF00082 | 0.493 |
CLV_PCSK_KEX2_1 | 287 | 289 | PF00082 | 0.492 |
CLV_PCSK_PC1ET2_1 | 185 | 187 | PF00082 | 0.433 |
CLV_PCSK_PC1ET2_1 | 287 | 289 | PF00082 | 0.547 |
CLV_PCSK_SKI1_1 | 182 | 186 | PF00082 | 0.433 |
CLV_PCSK_SKI1_1 | 218 | 222 | PF00082 | 0.463 |
CLV_PCSK_SKI1_1 | 337 | 341 | PF00082 | 0.465 |
CLV_PCSK_SKI1_1 | 474 | 478 | PF00082 | 0.491 |
CLV_PCSK_SKI1_1 | 525 | 529 | PF00082 | 0.527 |
CLV_Separin_Metazoa | 70 | 74 | PF03568 | 0.536 |
DEG_APCC_DBOX_1 | 36 | 44 | PF00400 | 0.453 |
DOC_CYCLIN_RxL_1 | 182 | 192 | PF00134 | 0.543 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 305 | 314 | PF00134 | 0.394 |
DOC_CYCLIN_yCln2_LP_2 | 416 | 422 | PF00134 | 0.449 |
DOC_MAPK_DCC_7 | 453 | 463 | PF00069 | 0.424 |
DOC_MAPK_gen_1 | 287 | 293 | PF00069 | 0.454 |
DOC_MAPK_gen_1 | 37 | 45 | PF00069 | 0.435 |
DOC_MAPK_gen_1 | 408 | 416 | PF00069 | 0.454 |
DOC_MAPK_gen_1 | 497 | 505 | PF00069 | 0.444 |
DOC_MAPK_MEF2A_6 | 408 | 416 | PF00069 | 0.465 |
DOC_PP4_FxxP_1 | 346 | 349 | PF00568 | 0.466 |
DOC_WW_Pin1_4 | 104 | 109 | PF00397 | 0.628 |
DOC_WW_Pin1_4 | 117 | 122 | PF00397 | 0.496 |
DOC_WW_Pin1_4 | 155 | 160 | PF00397 | 0.444 |
DOC_WW_Pin1_4 | 16 | 21 | PF00397 | 0.624 |
DOC_WW_Pin1_4 | 525 | 530 | PF00397 | 0.555 |
LIG_14-3-3_CanoR_1 | 27 | 32 | PF00244 | 0.600 |
LIG_Actin_WH2_2 | 159 | 175 | PF00022 | 0.452 |
LIG_Actin_WH2_2 | 87 | 102 | PF00022 | 0.557 |
LIG_APCC_ABBA_1 | 291 | 296 | PF00400 | 0.381 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.646 |
LIG_BRCT_BRCA1_1 | 250 | 254 | PF00533 | 0.505 |
LIG_BRCT_BRCA1_2 | 250 | 256 | PF00533 | 0.485 |
LIG_EH_1 | 87 | 91 | PF12763 | 0.591 |
LIG_FHA_1 | 189 | 195 | PF00498 | 0.502 |
LIG_FHA_1 | 201 | 207 | PF00498 | 0.449 |
LIG_FHA_1 | 272 | 278 | PF00498 | 0.420 |
LIG_FHA_1 | 359 | 365 | PF00498 | 0.459 |
LIG_FHA_1 | 374 | 380 | PF00498 | 0.293 |
LIG_FHA_1 | 424 | 430 | PF00498 | 0.401 |
LIG_FHA_1 | 473 | 479 | PF00498 | 0.471 |
LIG_FHA_1 | 60 | 66 | PF00498 | 0.521 |
LIG_FHA_2 | 135 | 141 | PF00498 | 0.569 |
LIG_FHA_2 | 279 | 285 | PF00498 | 0.489 |
LIG_HCF-1_HBM_1 | 510 | 513 | PF13415 | 0.484 |
LIG_LIR_Apic_2 | 343 | 349 | PF02991 | 0.482 |
LIG_LIR_Gen_1 | 234 | 243 | PF02991 | 0.410 |
LIG_LIR_Gen_1 | 251 | 262 | PF02991 | 0.187 |
LIG_LIR_Gen_1 | 279 | 285 | PF02991 | 0.491 |
LIG_LIR_Gen_1 | 32 | 43 | PF02991 | 0.478 |
LIG_LIR_Gen_1 | 325 | 336 | PF02991 | 0.488 |
LIG_LIR_Gen_1 | 454 | 463 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 234 | 239 | PF02991 | 0.415 |
LIG_LIR_Nem_3 | 251 | 257 | PF02991 | 0.192 |
LIG_LIR_Nem_3 | 279 | 283 | PF02991 | 0.443 |
LIG_LIR_Nem_3 | 32 | 38 | PF02991 | 0.572 |
LIG_LIR_Nem_3 | 325 | 331 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 415 | 420 | PF02991 | 0.549 |
LIG_LIR_Nem_3 | 454 | 458 | PF02991 | 0.428 |
LIG_LIR_Nem_3 | 510 | 516 | PF02991 | 0.509 |
LIG_PCNA_yPIPBox_3 | 308 | 319 | PF02747 | 0.431 |
LIG_Pex14_2 | 276 | 280 | PF04695 | 0.445 |
LIG_Pex14_2 | 448 | 452 | PF04695 | 0.436 |
LIG_SH2_CRK | 214 | 218 | PF00017 | 0.537 |
LIG_SH2_CRK | 513 | 517 | PF00017 | 0.506 |
LIG_SH2_GRB2like | 236 | 239 | PF00017 | 0.366 |
LIG_SH2_NCK_1 | 440 | 444 | PF00017 | 0.394 |
LIG_SH2_PTP2 | 236 | 239 | PF00017 | 0.403 |
LIG_SH2_SRC | 236 | 239 | PF00017 | 0.382 |
LIG_SH2_STAP1 | 250 | 254 | PF00017 | 0.507 |
LIG_SH2_STAP1 | 440 | 444 | PF00017 | 0.423 |
LIG_SH2_STAT3 | 33 | 36 | PF00017 | 0.557 |
LIG_SH2_STAT3 | 439 | 442 | PF00017 | 0.493 |
LIG_SH2_STAT5 | 236 | 239 | PF00017 | 0.389 |
LIG_SH2_STAT5 | 33 | 36 | PF00017 | 0.544 |
LIG_SH2_STAT5 | 440 | 443 | PF00017 | 0.359 |
LIG_SH2_STAT5 | 501 | 504 | PF00017 | 0.507 |
LIG_SH3_3 | 108 | 114 | PF00018 | 0.535 |
LIG_SH3_3 | 526 | 532 | PF00018 | 0.535 |
LIG_SH3_3 | 83 | 89 | PF00018 | 0.486 |
LIG_Sin3_3 | 295 | 302 | PF02671 | 0.427 |
LIG_SUMO_SIM_anti_2 | 386 | 392 | PF11976 | 0.382 |
LIG_SUMO_SIM_par_1 | 296 | 304 | PF11976 | 0.442 |
LIG_TRAF2_1 | 114 | 117 | PF00917 | 0.623 |
LIG_TRAF2_1 | 491 | 494 | PF00917 | 0.512 |
LIG_TYR_ITIM | 432 | 437 | PF00017 | 0.523 |
LIG_UBA3_1 | 240 | 248 | PF00899 | 0.519 |
LIG_WRC_WIRS_1 | 277 | 282 | PF05994 | 0.485 |
LIG_WRC_WIRS_1 | 479 | 484 | PF05994 | 0.501 |
MOD_CDK_SPK_2 | 104 | 109 | PF00069 | 0.587 |
MOD_CK1_1 | 120 | 126 | PF00069 | 0.434 |
MOD_CK1_1 | 200 | 206 | PF00069 | 0.466 |
MOD_CK1_1 | 355 | 361 | PF00069 | 0.513 |
MOD_CK1_1 | 481 | 487 | PF00069 | 0.524 |
MOD_CK2_1 | 104 | 110 | PF00069 | 0.551 |
MOD_CK2_1 | 134 | 140 | PF00069 | 0.559 |
MOD_CK2_1 | 192 | 198 | PF00069 | 0.495 |
MOD_CK2_1 | 453 | 459 | PF00069 | 0.439 |
MOD_CK2_1 | 488 | 494 | PF00069 | 0.470 |
MOD_CK2_1 | 64 | 70 | PF00069 | 0.566 |
MOD_Cter_Amidation | 285 | 288 | PF01082 | 0.530 |
MOD_GlcNHglycan | 192 | 197 | PF01048 | 0.456 |
MOD_GlcNHglycan | 328 | 331 | PF01048 | 0.480 |
MOD_GlcNHglycan | 354 | 357 | PF01048 | 0.441 |
MOD_GSK3_1 | 16 | 23 | PF00069 | 0.626 |
MOD_GSK3_1 | 188 | 195 | PF00069 | 0.453 |
MOD_N-GLC_1 | 104 | 109 | PF02516 | 0.613 |
MOD_N-GLC_1 | 59 | 64 | PF02516 | 0.559 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.379 |
MOD_NEK2_1 | 206 | 211 | PF00069 | 0.394 |
MOD_NEK2_1 | 276 | 281 | PF00069 | 0.449 |
MOD_NEK2_1 | 310 | 315 | PF00069 | 0.452 |
MOD_NEK2_1 | 486 | 491 | PF00069 | 0.442 |
MOD_NEK2_1 | 90 | 95 | PF00069 | 0.487 |
MOD_NEK2_2 | 213 | 218 | PF00069 | 0.549 |
MOD_NEK2_2 | 472 | 477 | PF00069 | 0.535 |
MOD_PIKK_1 | 157 | 163 | PF00454 | 0.414 |
MOD_PIKK_1 | 271 | 277 | PF00454 | 0.473 |
MOD_PIKK_1 | 438 | 444 | PF00454 | 0.428 |
MOD_PIKK_1 | 481 | 487 | PF00454 | 0.535 |
MOD_PKA_2 | 423 | 429 | PF00069 | 0.491 |
MOD_Plk_1 | 192 | 198 | PF00069 | 0.453 |
MOD_Plk_1 | 373 | 379 | PF00069 | 0.417 |
MOD_Plk_1 | 453 | 459 | PF00069 | 0.439 |
MOD_Plk_1 | 59 | 65 | PF00069 | 0.519 |
MOD_Plk_2-3 | 300 | 306 | PF00069 | 0.532 |
MOD_Plk_2-3 | 454 | 460 | PF00069 | 0.439 |
MOD_Plk_4 | 120 | 126 | PF00069 | 0.454 |
MOD_Plk_4 | 310 | 316 | PF00069 | 0.435 |
MOD_Plk_4 | 478 | 484 | PF00069 | 0.481 |
MOD_Plk_4 | 52 | 58 | PF00069 | 0.528 |
MOD_Plk_4 | 90 | 96 | PF00069 | 0.465 |
MOD_ProDKin_1 | 104 | 110 | PF00069 | 0.634 |
MOD_ProDKin_1 | 117 | 123 | PF00069 | 0.486 |
MOD_ProDKin_1 | 155 | 161 | PF00069 | 0.440 |
MOD_ProDKin_1 | 16 | 22 | PF00069 | 0.622 |
MOD_ProDKin_1 | 525 | 531 | PF00069 | 0.543 |
MOD_SUMO_for_1 | 505 | 508 | PF00179 | 0.538 |
MOD_SUMO_rev_2 | 139 | 143 | PF00179 | 0.474 |
TRG_DiLeu_BaEn_1 | 534 | 539 | PF01217 | 0.495 |
TRG_ENDOCYTIC_2 | 214 | 217 | PF00928 | 0.475 |
TRG_ENDOCYTIC_2 | 236 | 239 | PF00928 | 0.403 |
TRG_ENDOCYTIC_2 | 434 | 437 | PF00928 | 0.457 |
TRG_ENDOCYTIC_2 | 513 | 516 | PF00928 | 0.425 |
TRG_ER_diArg_1 | 217 | 219 | PF00400 | 0.494 |
TRG_ER_diArg_1 | 37 | 40 | PF00400 | 0.477 |
TRG_ER_diArg_1 | 411 | 414 | PF00400 | 0.447 |
TRG_ER_diArg_1 | 99 | 101 | PF00400 | 0.576 |
TRG_NES_CRM1_1 | 312 | 326 | PF08389 | 0.516 |
TRG_Pf-PMV_PEXEL_1 | 141 | 145 | PF00026 | 0.550 |
TRG_Pf-PMV_PEXEL_1 | 185 | 189 | PF00026 | 0.550 |
TRG_Pf-PMV_PEXEL_1 | 73 | 77 | PF00026 | 0.432 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I018 | Leptomonas seymouri | 69% | 100% |
A0A0S4KHA2 | Bodo saltans | 53% | 100% |
A0A1X0P0I1 | Trypanosomatidae | 22% | 94% |
A0A1X0P129 | Trypanosomatidae | 56% | 100% |
A0A3R7LEP3 | Trypanosoma rangeli | 24% | 92% |
A0A3R7P546 | Trypanosoma rangeli | 57% | 100% |
A4HPZ4 | Leishmania braziliensis | 87% | 100% |
A4IDQ5 | Leishmania infantum | 100% | 100% |
D0A4E6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 23% | 96% |
D0A4E7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 57% | 100% |
E9ATR1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4Q0T6 | Leishmania major | 96% | 100% |
V5B501 | Trypanosoma cruzi | 24% | 90% |
V5BKI7 | Trypanosoma cruzi | 58% | 100% |